Cargando…
Pancreatic stone protein point-of-care testing can reduce healthcare expenditure in sepsis
BACKGROUND: Sepsis is a life-threatening organ dysfunction in response to infection. Early recognition and rapid treatment are critical to patient outcomes and cost savings, but sepsis is difficult to diagnose because of its non-specific symptoms. Biomarkers such as pancreatic stone protein (PSP) of...
Autores principales: | Schneider, John E., Dick, Katherine, Cooper, Jacie T., Chami, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9306195/ https://www.ncbi.nlm.nih.gov/pubmed/35867213 http://dx.doi.org/10.1186/s13561-022-00381-z |
Ejemplares similares
-
Pancreatic stone protein as a biomarker of sepsis
por: Lopes, Diogo, et al.
Publicado: (2022) -
Pancreatic stone protein as a novel marker for neonatal sepsis
por: Schlapbach, L, et al.
Publicado: (2012) -
Pancreatic Stone Protein: Review of a New Biomarker in Sepsis
por: Fidalgo, Pedro, et al.
Publicado: (2022) -
The Role of Pancreatic Stone Protein in Diagnosis of Early Onset Neonatal Sepsis
por: Rass, Anwar A., et al.
Publicado: (2016) -
Exploratory analysis of the potential for advanced diagnostic testing to reduce healthcare expenditures of patients hospitalized with meningitis or encephalitis
por: Fulton, Brent D., et al.
Publicado: (2020)